Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Traws Pharma (TRAW) Free Cash Flow (2016 - 2025)

Traws Pharma's Free Cash Flow history spans 14 years, with the latest figure at -$2.8 million for Q4 2025.

  • Quarterly results put Free Cash Flow at -$2.8 million for Q4 2025, up 31.73% from a year ago — trailing twelve months through Dec 2025 was -$18.2 million (up 38.96% YoY), and the annual figure for FY2025 was -$20.8 million, up 37.89%.
  • Free Cash Flow for Q4 2025 was -$2.8 million at Traws Pharma, up from -$4.0 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of -$2.8 million in Q4 2025 to a low of -$11.5 million in Q3 2024.
  • The 5-year median for Free Cash Flow is -$4.4 million (2021), against an average of -$5.1 million.
  • The sharpest move saw Free Cash Flow plummeted 156.79% in 2024, then surged 65.05% in 2025.
  • Year by year, Free Cash Flow stood at -$4.3 million in 2021, then grew by 8.93% to -$3.9 million in 2022, then dropped by 14.06% to -$4.4 million in 2023, then increased by 8.8% to -$4.0 million in 2024, then surged by 31.73% to -$2.8 million in 2025.
  • According to Business Quant data, Free Cash Flow over the past three periods came in at -$2.8 million, -$4.0 million, and -$6.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.